Vext Science, Inc.
VEXT
CNSX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 13.43% | 6.65% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.43% | 6.65% | |||
| Cost of Revenue | 60.56% | -26.98% | |||
| Gross Profit | -46.18% | 155.36% | |||
| SG&A Expenses | -5.84% | -0.06% | |||
| Depreciation & Amortization | -2.47% | -2.31% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 30.96% | -15.66% | |||
| Operating Income | -153.03% | 65.67% | |||
| Income Before Tax | -163.03% | 39.44% | |||
| Income Tax Expenses | 945.73% | -87.74% | |||
| Earnings from Continuing Operations | -269.07% | 43.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -269.07% | 43.13% | |||
| EBIT | -153.03% | 65.67% | |||
| EBITDA | -85.30% | 4,718.66% | |||
| EPS Basic | -264.71% | 43.02% | |||
| Normalized Basic EPS | -244.44% | 53.04% | |||
| EPS Diluted | -264.71% | 43.02% | |||
| Normalized Diluted EPS | -250.94% | 53.91% | |||
| Average Basic Shares Outstanding | 0.77% | 0.04% | |||
| Average Diluted Shares Outstanding | -0.49% | 1.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||